MRI Performance and Risk Factors in Bilateral Vestibular Hypofunction
MPARFIBVH
The Clinical Trial Protocol: MRI Performance and Risk Factors of Bilateral Vestibular Hypofunction: A Multi-center Cross-sectional Study
2 other identifiers
observational
120
1 country
1
Brief Summary
Bilateral vestibular hypofunction (BVH) is a chronic disorder in which the balance organs or vestibular pathways on both sides do not work normally. People with BVH may experience unsteadiness, blurred or unstable vision during head movement, difficulty walking, and an increased risk of falls. At present, there are limited targeted medical treatments, and the reasons why symptoms are severe in some patients but mild in others are not fully understood. This prospective, multicenter, cross-sectional study will investigate the relationships among vestibular function, brain structure and function, blood biomarkers, patient-reported symptoms, and disease severity in people with BVH. The study will enroll approximately 120 participants from five medical centers in China, including about 80 patients with BVH and 40 age-matched healthy controls. Participants will undergo vestibular function tests, including videonystagmography, caloric testing, sinusoidal harmonic acceleration testing, video head impulse testing, vestibular evoked myogenic potentials, and sensory organization testing. Brain imaging will include resting-state functional magnetic resonance imaging, diffusion tensor imaging, and diffusion kurtosis imaging. Participants will also complete questionnaires related to dizziness, anxiety and depression, daily activities, and symptom severity, and blood samples will be collected for biochemical and inflammatory marker testing. The main hypothesis is that BVH severity is associated with measurable changes in vestibular function, brain functional connectivity and microstructure, inflammatory or metabolic biomarkers, and patient-reported quality of life. By combining clinical testing, neuroimaging, laboratory measures, and symptom scales, this study aims to improve understanding of the mechanisms of BVH and to support future development of more individualized diagnostic and rehabilitation strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 11, 2024
CompletedFirst Submitted
Initial submission to the registry
July 11, 2026
CompletedFirst Posted
Study publicly available on registry
July 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
July 16, 2026
July 1, 2026
5.2 years
July 11, 2026
July 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dizziness Handicap Inventory
The Dizziness Handicap Inventory is a 25-item questionnaire used to assess perceived vestibular disability. Each item is scored using three response categories of 0, 2, or 4, with a total score ranging from 0 to 100; higher scores indicate greater dizziness-related handicap. Severity is categorized as mild 0-30, moderate 30-60, and severe 61-100.
Within 1 month after enrollment
Secondary Outcomes (4)
Vestibular Disorders Activities of Daily Living Scale
Within 1 month after enrollment
Hospital Anxiety and Depression Scale
Within 1 month after enrollment
Visual Analog Scale
Within 1 month after enrollment
Video Head Impulse Test
Within 1 month after enrollment
Study Arms (2)
patients
Participants diagnosed with bilateral vestibular hypofunction, including bilateral vestibulopathy or presbyvestibulopathy. Participants in this group will undergo vestibular function tests, magnetic resonance imaging, patient-reported clinical scales, and laboratory assessments.
healthy controls
Age-matched healthy control participants without bilateral vestibular hypofunction. Participants in this group will undergo the same study assessments, including vestibular function tests, magnetic resonance imaging, patient-reported clinical scales, and laboratory assessments, as applicable according to the study protocol.
Interventions
Participants will undergo multimodal neuroimaging and vestibular function assessments, including resting-state functional magnetic resonance imaging (rs-fMRI), diffusion tensor imaging (DTI), diffusion kurtosis imaging (DKI), and standardized vestibular function tests. Vestibular assessments include videonystagmography (VNG), caloric test (CT), sinusoidal harmonic acceleration test (SHAT), video head impulse test (vHIT), vestibular evoked myogenic potentials (VEMP), and sensory organization test (SOT). Participant-reported clinical scales and laboratory examinations will also be collected to evaluate the relationship between vestibular dysfunction, brain function, biochemical variables, quality of life, and BVH severity.
Eligibility Criteria
The study population will consist of participants aged over 16 years, including patients diagnosed with bilateral vestibular hypofunction (BVH) and age-matched healthy controls. Patients with BVH will include individuals meeting the diagnostic criteria for bilateral vestibulopathy (BVP) or presbyvestibulopathy (PVP). A total of 120 participants will be enrolled from five medical centers, including 80 BVH patients and 40 healthy controls. All participants must be able to understand the study procedures, comply with the protocol, communicate and cooperate with investigators, and provide written informed consent.
You may qualify if:
- Sex unrestricted, age over 16 years old.
- Patients meeting the diagnostic criteria for bilateral vestibulopathy (BVP) and presbyvestibulopathy (PVP)
- Participants or their legal representatives, who comprehensively understand the research purpose, demonstrate sufficient compliance with the study protocol, have the ability to communicate and cooperate, and have signed the informed consent form.
You may not qualify if:
- Administration of medications potentially affecting cerebral function, including psychotropic drugs (antidepressants, anxiolytics) or prolonged anti-vertigo medication usage.
- Presence of severe cardiovascular or systemic medical conditions, organ dysfunction, or significant mobility impairments.
- Significant local or systemic diseases, or psychiatric disorders causing cognitive impairment, specifically schizophrenia, major depressive disorder, or generalized anxiety disorder.
- Pregnant or lactating women.
- Participation in alternative pharmaceutical or medical device clinical trials within the preceding 3-month period.
- Clinically significant head movement restrictions.
- Subjects assessed by investigators as unsuitable for study participation.
- Individuals with contraindications for MRI, including cardiac pacemakers, implanted electronic devices, claustrophobia, metallic implants incompatible with magnetic resonance imaging and medications potentially compromising MRI scan safety.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
shanghai Jiao Tong University School of Medicine Affiliated Sixth People's Hospital
Shanghai, Shanghai Municipality, 200233, China
Related Publications (52)
Kellner E, Dhital B, Kiselev VG, Reisert M. Gibbs-ringing artifact removal based on local subvoxel-shifts. Magn Reson Med. 2016 Nov;76(5):1574-1581. doi: 10.1002/mrm.26054. Epub 2015 Nov 24.
PMID: 26745823BACKGROUNDLi J, Leng Y, Ma H, Yang F, Liu B, Fan W. Functional reorganization of intranetwork and internetwork connectivity in patients with Meniere's disease. Sci Rep. 2023 Oct 5;13(1):16775. doi: 10.1038/s41598-023-44090-x.
PMID: 37798378BACKGROUNDMcCrum C, Zhu M, Willems P, Visser I, Kastrinou M, van de Berg R, Meijer K, Hallemans A, Herssens N. Assessing gait variability concurrently with dynamic visual acuity on a treadmill in people with bilateral vestibulopathy. J Vestib Res. 2025 May;35(3):113-120. doi: 10.1177/09574271251313806. Epub 2025 Jan 10.
PMID: 39973592BACKGROUNDWu P, Cao W, Hu Y, Li H. Effects of vestibular rehabilitation, with or without betahistine, on managing residual dizziness after successful repositioning manoeuvres in patients with benign paroxysmal positional vertigo: a protocol for a randomised controlled trial. BMJ Open. 2019 Jun 18;9(6):e026711. doi: 10.1136/bmjopen-2018-026711.
PMID: 31217316BACKGROUNDSotiropoulos SN, Jbabdi S, Xu J, Andersson JL, Moeller S, Auerbach EJ, Glasser MF, Hernandez M, Sapiro G, Jenkinson M, Feinberg DA, Yacoub E, Lenglet C, Van Essen DC, Ugurbil K, Behrens TE; WU-Minn HCP Consortium. Advances in diffusion MRI acquisition and processing in the Human Connectome Project. Neuroimage. 2013 Oct 15;80:125-43. doi: 10.1016/j.neuroimage.2013.05.057. Epub 2013 May 20.
PMID: 23702418BACKGROUNDWasserthal J, Neher P, Maier-Hein KH. TractSeg - Fast and accurate white matter tract segmentation. Neuroimage. 2018 Dec;183:239-253. doi: 10.1016/j.neuroimage.2018.07.070. Epub 2018 Aug 4.
PMID: 30086412BACKGROUNDWasserthal J, Neher PF, Hirjak D, Maier-Hein KH. Combined tract segmentation and orientation mapping for bundle-specific tractography. Med Image Anal. 2019 Dec;58:101559. doi: 10.1016/j.media.2019.101559. Epub 2019 Sep 12.
PMID: 31542711BACKGROUNDJensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med. 2005 Jun;53(6):1432-40. doi: 10.1002/mrm.20508.
PMID: 15906300BACKGROUNDBasser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J. 1994 Jan;66(1):259-67. doi: 10.1016/S0006-3495(94)80775-1.
PMID: 8130344BACKGROUNDAndersson JLR, Sotiropoulos SN. An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. Neuroimage. 2016 Jan 15;125:1063-1078. doi: 10.1016/j.neuroimage.2015.10.019. Epub 2015 Oct 20.
PMID: 26481672BACKGROUNDVeraart J, Novikov DS, Christiaens D, Ades-Aron B, Sijbers J, Fieremans E. Denoising of diffusion MRI using random matrix theory. Neuroimage. 2016 Nov 15;142:394-406. doi: 10.1016/j.neuroimage.2016.08.016. Epub 2016 Aug 11.
PMID: 27523449BACKGROUNDBrilliant T D, Takeuchi H, Nouchi R, Yokoyama R, Kotozaki Y, Nakagawa S, Hanawa S, Sekiguchi A, Ikeda S, Sakaki K, Kawata KHDS, Nozawa T, Yokota S, Magistro D, Kawashima R. Loneliness inside of the brain: evidence from a large dataset of resting-state fMRI in young adult. Sci Rep. 2022 May 12;12(1):7856. doi: 10.1038/s41598-022-11724-5.
PMID: 35550564BACKGROUNDHerssens N, Dobbels B, Moyaert J, Van de Berg R, Saeys W, Hallemans A, Vereeck L, Van Rompaey V. Paving the Way Toward Distinguishing Fallers From Non-fallers in Bilateral Vestibulopathy: A Wide Pilot Observation. Front Neurol. 2021 Mar 1;12:611648. doi: 10.3389/fneur.2021.611648. eCollection 2021.
PMID: 33732204BACKGROUNDHassannia F, Misale P, Sulway S, Olmos GV, Dabiri S, Ranalli P, Rutka JA. Effectiveness of vestibular rehabilitation therapy in patients with idiopathic Cerebellar Ataxia with Bilateral Vestibulopathy (iCABV). J Vestib Res. 2022;32(5):479-485. doi: 10.3233/VES-210058.
PMID: 35527586BACKGROUNDBasta D, Rossi-Izquierdo M, Wonneberger K, Brugnera C, Bittar RSM, Greters ME, Ernst A, Soto-Varela A. Individualized Vibrotactile Neurofeedback Training in Patients with Chronic Bilateral Vestibulopathy. Brain Sci. 2023 Aug 18;13(8):1219. doi: 10.3390/brainsci13081219.
PMID: 37626575BACKGROUNDCohen HS, Kimball KT, Adams AS. Application of the vestibular disorders activities of daily living scale. Laryngoscope. 2000 Jul;110(7):1204-9. doi: 10.1097/00005537-200007000-00026.
PMID: 10892697BACKGROUNDZigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
PMID: 6880820BACKGROUNDJacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1990 Apr;116(4):424-7. doi: 10.1001/archotol.1990.01870040046011.
PMID: 2317323BACKGROUNDSteven AJ, Zhuo J, Melhem ER. Diffusion kurtosis imaging: an emerging technique for evaluating the microstructural environment of the brain. AJR Am J Roentgenol. 2014 Jan;202(1):W26-33. doi: 10.2214/AJR.13.11365.
PMID: 24370162BACKGROUNDBrown-Lum M, Izadi-Najafabadi S, Oberlander TF, Rauscher A, Zwicker JG. Differences in White Matter Microstructure Among Children With Developmental Coordination Disorder. JAMA Netw Open. 2020 Mar 2;3(3):e201184. doi: 10.1001/jamanetworkopen.2020.1184.
PMID: 32186744BACKGROUNDGottlich M, Jandl NM, Wojak JF, Sprenger A, von der Gablentz J, Munte TF, Kramer UM, Helmchen C. Altered resting-state functional connectivity in patients with chronic bilateral vestibular failure. Neuroimage Clin. 2014 Mar 12;4:488-99. doi: 10.1016/j.nicl.2014.03.003. eCollection 2014.
PMID: 24818075BACKGROUNDXu Z, Tan T, Jiang Y, Tang H, Chen B, Chen W, Yuan Y. Resting-state functional magnetic resonance imaging and tryptophan hydroxylase-2 methylation interaction in major depressive disorder. Brain Res Bull. 2025 Sep;229:111469. doi: 10.1016/j.brainresbull.2025.111469. Epub 2025 Jul 15.
PMID: 40675265BACKGROUNDFox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci. 2007 Sep;8(9):700-11. doi: 10.1038/nrn2201.
PMID: 17704812BACKGROUNDKierig E, Gerb J, Boegle R, Ertl-Wagner B, Dieterich M, Kirsch V. Vestibular paroxysmia entails vestibular nerve function, microstructure and endolymphatic space changes linked to root-entry zone neurovascular compression. J Neurol. 2023 Jan;270(1):82-100. doi: 10.1007/s00415-022-11399-y. Epub 2022 Oct 18.
PMID: 36255522BACKGROUNDBubenikova A, Vlasak A, Fik Z, Sedlak V, Tesarova M, Bradac O. Application of diffusion tensor imaging of the facial nerve in preoperative planning for large vestibular schwannoma: a systematic review. Neurosurg Rev. 2023 Nov 11;46(1):298. doi: 10.1007/s10143-023-02214-x.
PMID: 37950058BACKGROUNDGard A, Al-Husseini A, Kornaropoulos EN, De Maio A, Tegner Y, Bjorkman-Burtscher I, Markenroth Bloch K, Nilsson M, Magnusson M, Marklund N. Post-Concussive Vestibular Dysfunction Is Related to Injury to the Inferior Vestibular Nerve. J Neurotrauma. 2022 Jun;39(11-12):829-840. doi: 10.1089/neu.2021.0447. Epub 2022 Mar 7.
PMID: 35171721BACKGROUNDLin L, Chen X, Jiang R, Zhong T, Du X, Xu G, Duan Q, Xue Y. Differentiation between vestibular schwannomas and meningiomas with atypical appearance using diffusion kurtosis imaging and three-dimensional arterial spin labeling imaging. Eur J Radiol. 2018 Dec;109:13-18. doi: 10.1016/j.ejrad.2018.10.009. Epub 2018 Oct 12.
PMID: 30527294BACKGROUNDChen Z, Liu Y, Lin C, Li Z, Shan J, Duan Z, Rong L, Wei X, Xiao L, Liu H. Aberrant cerebral blood flow and functional connectivity in patients with vestibular migraine: a resting-state ASL and fMRI study. J Headache Pain. 2024 May 21;25(1):84. doi: 10.1186/s10194-024-01792-5.
PMID: 38773396BACKGROUNDXiong X, Dai L, Chen W, Lu J, Hu C, Zhao H, Ke J. Dynamics and concordance alterations of regional brain function indices in vestibular migraine: a resting-state fMRI study. J Headache Pain. 2024 Jan 5;25(1):1. doi: 10.1186/s10194-023-01705-y.
PMID: 38178029BACKGROUNDWu J, Shu L, Zhou CY, Du XX, Sun XH, Pan H, Cui GH, Liu JR, Chen W. Brain Functional Alterations in Patients With Benign Paroxysmal Positional Vertigo Demonstrate the Visual-Vestibular Interaction and Integration. Brain Behav. 2024 Oct;14(10):e70053. doi: 10.1002/brb3.70053.
PMID: 39350430BACKGROUNDLee SY, Lee DH, Bae YJ, Song JJ, Kim JS, Koo JW. Bilateral Vestibulopathy in Superficial Siderosis. Front Neurol. 2018 Jun 6;9:422. doi: 10.3389/fneur.2018.00422. eCollection 2018.
PMID: 29928256BACKGROUNDYip CW, Strupp M. The Dizziness Handicap Inventory does not correlate with vestibular function tests: a prospective study. J Neurol. 2018 May;265(5):1210-1218. doi: 10.1007/s00415-018-8834-7. Epub 2018 Mar 20.
PMID: 29557501BACKGROUNDSteensnaes MH, Knapstad MK, Goplen FK, Berge JE. Persistent Postural-Perceptual Dizziness (PPPD) and quality of life: a cross-sectional study. Eur Arch Otorhinolaryngol. 2023 Dec;280(12):5285-5292. doi: 10.1007/s00405-023-08040-7. Epub 2023 May 31.
PMID: 37256345BACKGROUNDLucieer FMP, Van Hecke R, van Stiphout L, Duijn S, Perez-Fornos A, Guinand N, Van Rompaey V, Kingma H, Joore M, van de Berg R. Bilateral vestibulopathy: beyond imbalance and oscillopsia. J Neurol. 2020 Dec;267(Suppl 1):241-255. doi: 10.1007/s00415-020-10243-5. Epub 2020 Oct 8.
PMID: 33030608BACKGROUNDLee ES, Weon YC, Kim JS, Lee TK, Park JY. Functional and anatomical alterations in bilateral vestibulopathy: A multimodal neuroimaging study and clinical correlation. Front Neurol. 2023 Mar 30;14:1157931. doi: 10.3389/fneur.2023.1157931. eCollection 2023.
PMID: 37064188BACKGROUNDStarkov D, Strupp M, Pleshkov M, Kingma H, van de Berg R. Diagnosing vestibular hypofunction: an update. J Neurol. 2021 Jan;268(1):377-385. doi: 10.1007/s00415-020-10139-4. Epub 2020 Aug 7.
PMID: 32767115BACKGROUNDDorbeau C, Bourget K, Renard L, Calais C, Bakhos D. Vestibular evoked myogenic potentials. Eur Ann Otorhinolaryngol Head Neck Dis. 2021 Dec;138(6):483-488. doi: 10.1016/j.anorl.2021.01.001. Epub 2021 Jan 19.
PMID: 33483282BACKGROUNDGrove CR, Whitney SL, Hetzel SJ, Heiderscheit BC, Pyle GM. Validation of a next-generation sensory organization test in adults with and without vestibular dysfunction. J Vestib Res. 2021;31(1):33-45. doi: 10.3233/VES-200040.
PMID: 33325418BACKGROUNDLoos E, Van Stiphout L, Lucieer F, Guinand N, Perez-Fornos A, Van Rompaey V, Desloovere C, Denys S, Verhaert N, van de Berg R. The evolution of vestibular function and health-related quality of life in bilateral vestibulopathy. Sci Rep. 2025 Mar 3;15(1):7476. doi: 10.1038/s41598-025-92109-2.
PMID: 40033069BACKGROUNDAnson ER, Kiemel T, Carey JP, Jeka JJ. Eye Movements Are Correctly Timed During Walking Despite Bilateral Vestibular Hypofunction. J Assoc Res Otolaryngol. 2017 Aug;18(4):591-600. doi: 10.1007/s10162-017-0626-8. Epub 2017 Jun 7.
PMID: 28593438BACKGROUNDSzmulewicz DJ, Waterston JA, Halmagyi GM, Mossman S, Chancellor AM, McLean CA, Storey E. Sensory neuropathy as part of the cerebellar ataxia neuropathy vestibular areflexia syndrome. Neurology. 2011 May 31;76(22):1903-10. doi: 10.1212/WNL.0b013e31821d746e.
PMID: 21624989BACKGROUNDBae SH, Nam GS, Kwak SH, Kim SH. Importance of High-Frequency Vestibular Function in the Prognosis of Bilateral Vestibulopathy. Clin Exp Otorhinolaryngol. 2021 May;14(2):192-199. doi: 10.21053/ceo.2020.01739. Epub 2020 Nov 16.
PMID: 33197308BACKGROUNDPellerin D, Heindl F, Traschutz A, Rujescu D, Hartmann AM, Brais B, Houlden H, Dufke C, Riess O, Haack T, Strupp M, Synofzik M. RFC1 repeat expansions in downbeat nystagmus syndromes: frequency and phenotypic profile. J Neurol. 2024 May;271(5):2886-2892. doi: 10.1007/s00415-024-12229-z. Epub 2024 Feb 21.
PMID: 38381176BACKGROUNDVermorken BL, Volpe B, van Boxel SCJ, Stultiens JJA, van Hoof M, Marcellis R, Loos E, van Soest A, McCrum C, Meijer K, Guinand N, Perez Fornos A, van Rompaey V, Devocht E, van de Berg R. The VertiGO! Trial protocol: A prospective, single-center, patient-blinded study to evaluate efficacy and safety of prolonged daily stimulation with a multichannel vestibulocochlear implant prototype in bilateral vestibulopathy patients. PLoS One. 2024 Mar 28;19(3):e0301032. doi: 10.1371/journal.pone.0301032. eCollection 2024.
PMID: 38547135BACKGROUNDSun DQ, Ward BK, Semenov YR, Carey JP, Della Santina CC. Bilateral Vestibular Deficiency: Quality of Life and Economic Implications. JAMA Otolaryngol Head Neck Surg. 2014 Jun;140(6):527-34. doi: 10.1001/jamaoto.2014.490.
PMID: 24763518BACKGROUNDZingler VC, Cnyrim C, Jahn K, Weintz E, Fernbacher J, Frenzel C, Brandt T, Strupp M. Causative factors and epidemiology of bilateral vestibulopathy in 255 patients. Ann Neurol. 2007 Jun;61(6):524-32. doi: 10.1002/ana.21105.
PMID: 17393465BACKGROUNDChow MR, Ayiotis AI, Schoo DP, Gimmon Y, Lane KE, Morris BJ, Rahman MA, Valentin NS, Boutros PJ, Bowditch SP, Ward BK, Sun DQ, Trevino Guajardo C, Schubert MC, Carey JP, Della Santina CC. Posture, Gait, Quality of Life, and Hearing with a Vestibular Implant. N Engl J Med. 2021 Feb 11;384(6):521-532. doi: 10.1056/NEJMoa2020457.
PMID: 33567192BACKGROUNDvan Dooren TS, Starkov D, Lucieer FMP, Vermorken B, Janssen AML, Guinand N, Perez-Fornos A, Van Rompaey V, Kingma H, van de Berg R. Comparison of three video head impulse test systems for the diagnosis of bilateral vestibulopathy. J Neurol. 2020 Dec;267(Suppl 1):256-264. doi: 10.1007/s00415-020-10060-w. Epub 2020 Jul 27.
PMID: 32719974BACKGROUNDDobbels B, Lucieer F, Mertens G, Gilles A, Moyaert J, van de Heyning P, Guinand N, Perez Fornos A, Herssens N, Hallemans A, Vereeck L, Vanderveken O, Van Rompaey V, van de Berg R. Prospective cohort study on the predictors of fall risk in 119 patients with bilateral vestibulopathy. PLoS One. 2020 Mar 9;15(3):e0228768. doi: 10.1371/journal.pone.0228768. eCollection 2020.
PMID: 32150553BACKGROUNDAgrawal Y, Van de Berg R, Wuyts F, Walther L, Magnusson M, Oh E, Sharpe M, Strupp M. Presbyvestibulopathy: Diagnostic criteria Consensus document of the classification committee of the Barany Society. J Vestib Res. 2019;29(4):161-170. doi: 10.3233/VES-190672.
PMID: 31306146BACKGROUNDStrupp M, Kim JS, Murofushi T, Straumann D, Jen JC, Rosengren SM, Della Santina CC, Kingma H. Bilateral vestibulopathy: Diagnostic criteria Consensus document of the Classification Committee of the Barany Society. J Vestib Res. 2017;27(4):177-189. doi: 10.3233/VES-170619.
PMID: 29081426BACKGROUNDWard BK, Agrawal Y, Hoffman HJ, Carey JP, Della Santina CC. Prevalence and impact of bilateral vestibular hypofunction: results from the 2008 US National Health Interview Survey. JAMA Otolaryngol Head Neck Surg. 2013 Aug 1;139(8):803-10. doi: 10.1001/jamaoto.2013.3913.
PMID: 23949355BACKGROUND
Biospecimen
Blood samples will be collected from enrolled participants for laboratory assessments, including biochemical, metabolic, inflammatory, and anti-inflammatory biomarkers. Planned assessments include lipid profile, glucose metabolism-related indicators, liver and renal function-related indicators, inflammatory biomarkers, anti-inflammatory biomarkers, and apolipoprotein E genotyping. Samples may be used for DNA extraction for the planned genotyping analysis.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Otolaryngology Institute of Shanghai Jiao Tong University, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Study Record Dates
First Submitted
July 11, 2026
First Posted
July 16, 2026
Study Start
October 11, 2024
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2029
Last Updated
July 16, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- De-identified IPD and supporting information will become available beginning 1 year after publication of the main study results and will remain available for 5 years following publication.
- Access Criteria
- Access will be granted to qualified researchers who submit a methodologically sound research proposal for scientific purposes related to bilateral vestibular hypofunction, vestibular disorders, neuroimaging, or related clinical research. Requests will be reviewed by the principal investigator and the relevant ethics committee. Data will be shared only after approval of the request and execution of a data access agreement. Shared data may include de-identified clinical scale scores, vestibular function test results, laboratory variables, and processed neuroimaging-derived measures. Direct identifiers and raw imaging data will not be shared unless specifically approved by the ethics committee.
De-identified individual participant data underlying the published results may be shared with qualified researchers upon reasonable request after publication of the main study results, subject to approval by the relevant ethics committee and execution of a data access agreement. Shared data may include clinical scale scores, vestibular function test results, laboratory variables, and processed neuroimaging-derived measures. Direct identifiers and raw imaging data will not be shared unless specifically approved by the ethics committee.